Inflammasome-mediated secretion of IL-1bin human monocytes through TLR2 activation; Modulation by dietary fatty acids

Journal of Immunology

Volumn 191, Issue 8, 2013, Pages 4337-4347

  Snodgrass, Ryan G ^a,b   Huang, Shurong ^a   Choi, Il Whan ^c   Rutledge, John C ^d   Hwang, Daniel H ^a,b  

^a U S DEPARTMENT OF AGRICULTURE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Inje University   (South Korea)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOPYRIN; DOCOSAHEXAENOIC ACID; INFLAMMASOME; INTERLEUKIN 1BETA; OMEGA 3 FATTY ACID; PALMITIC ACID; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 6;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DIMERIZATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME MODIFICATION; FAT INTAKE; HUMAN; HUMAN CELL; IMMUNOMODULATION; LIPID RAFT; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

CARRIER PROTEINS; CASPASE 1; CELL LINE; CRYSTALLOGRAPHY, X-RAY; DIETARY FATS; DIMERIZATION; DOCOSAHEXAENOIC ACIDS; ENZYME ACTIVATION; FATTY ACIDS; HUMANS; INFLAMMASOMES; INFLAMMATION; INSULIN RESISTANCE; INTERLEUKIN-1BETA; MONOCYTES; NADPH OXIDASE; PALMITIC ACID; PROTEIN MULTIMERIZATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; TOLL-LIKE RECEPTOR 1; TOLL-LIKE RECEPTOR 2; UP-REGULATION;

EID: 84885467630     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300298     Document Type: Article

References (89)

1. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
2. Geissmann, F., M. G. Manz, S. Jung, M. H. Sieweke, M. Merad, and K. Ley. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
3. Nguyen, M. T., S. Favelyukis, A. K. Nguyen, D. Reichart, P. A. Scott, A. Jenn, R. Liu-Bryan, C. K. Glass, J. G. Neels, and J. M. Olefsky. 2007. A subpopulation of macrophages infiltrates hypertrophic adipose tissue and is activated by free fatty acids via Toll-like receptors 2 and 4 and JNK-dependent pathways. J. Biol. Chem. 282: 35279-35292.
4. Bryant, C., and K. A. Fitzgerald. 2009. Molecular mechanisms involved in inflammasome activation. Trends Cell Biol. 19: 455-464.
5. Lamkanfi, M., and V. M. Dixit. 2009. The inflammasomes. PLoS Pathog. 5: e1000510.
6. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proILbeta. Mol. Cell 10: 417-426.
7. Martinon, F., A. Mayor, and J. Tschopp. 2009. The inflammasomes: guardians of the body. Annu. Rev. Immunol. 27: 229-265.
8. Carta, S., S. Tassi, I. Pettinati, L. Delfino, C. A. Dinarello, and A. Rubartelli. 2011. The rate of interleukin-1beta secretion in different myeloid cells varies with the extent of redox response to Toll-like receptor triggering. J. Biol. Chem. 286: 27069-27080.
9. Netea, M. G., C. A. Nold-Petry, M. F. Nold, L. A. Joosten, B. Opitz, J. H. van der Meer, F. L. van de Veerdonk, G. Ferwerda, B. Heinhuis, I. Devesa, et al. 2009. Differential requirement for the activation of the inflammasome for processing and release of IL-1beta in monocytes and macrophages. Blood 113: 2324-2335.
10. Netea, M. G., A. Simon, F. van de Veerdonk, B. J. Kullberg, J. W. Van der Meer, and L. A. Joosten. 2010. IL-1beta processing in host defense: beyond the inflammasomes. PLoS Pathog. 6: e1000661.
11. He, Y., L. Franchi, and G. Núñez. 2013. TLR agonists stimulate Nlrp3-dependent IL-1b production independently of the purinergic P2X7 receptor in dendritic cells and in vivo. J. Immunol. 190: 334-339.
12. Krysko, D. V., P. Agostinis, O. Krysko, A. D. Garg, C. Bachert, B. N. Lambrecht, and P. Vandenabeele. 2011. Emerging role of damage-Associated molecular patterns derived from mitochondria in inflammation. Trends Immunol. 32: 157-164.
13. Piccinini, A. M., and K. S. Midwood. 2010. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010: pii:672395.
14. Holland, W. L., B. T. Bikman, L. P. Wang, G. Yuguang, K. M. Sargent, S. Bulchand, T. A. Knotts, G. Shui, D. J. Clegg, M. R. Wenk, et al. 2011. Lipidinduced insulin resistance mediated by the proinflammatory receptor TLR4 requires saturated fatty acid-induced ceramide biosynthesis in mice. J. Clin. Invest. 121: 1858-1870.
15. Hwang, D. 2001. Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways. FASEB J. 15: 2556-2564.
16. Shi, H., M. V. Kokoeva, K. Inouye, I. Tzameli, H. Yin, and J. S. Flier. 2006. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116: 3015-3025.
17. Stienstra, R., J. A. van Diepen, C. J. Tack, M. H. Zaki, F. L. van de Veerdonk, D. Perera, G. A. Neale, G. J. Hooiveld, A. Hijmans, I. Vroegrijk, et al. 2011. Inflammasome is a central player in the induction of obesity and insulin resistance. Proc. Natl. Acad. Sci. USA 108: 15324-15329.
18. Vandanmagsar, B., Y. H. Youm, A. Ravussin, J. E. Galgani, K. Stadler, R. L. Mynatt, E. Ravussin, J. M. Stephens, and V. D. Dixit. 2011. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 17: 179-188.
19. Wen, H., D. Gris, Y. Lei, S. Jha, L. Zhang, M. T. Huang, W. J. Brickey, and J. P. Ting. 2011. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 12: 408-415.
20. Lee, J. Y., A. Plakidas, W. H. Lee, A. Heikkinen, P. Chanmugam, G. Bray, and D. H. Hwang. 2003. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J. Lipid Res. 44: 479-486.
21. Lee, J. Y., K. H. Sohn, S. H. Rhee, and D. Hwang. 2001. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4. J. Biol. Chem. 276: 16683-16689.
22. Lee, J. Y., J. Ye, Z. Gao, H. S. Youn, W. H. Lee, L. Zhao, N. Sizemore, and D. H. Hwang. 2003. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty acids. J. Biol. Chem. 278: 37041-37051.
23. Lee, J. Y., L. Zhao, H. S. Youn, A. R. Weatherill, R. Tapping, L. Feng, W. H. Lee, K. A. Fitzgerald, and D. H. Hwang. 2004. Saturated fatty acid activates but polyunsaturated fatty acid inhibits Toll-like receptor 2 dimerized with Toll-like receptor 6 or 1. J. Biol. Chem. 279: 16971-16979.
24. Weatherill, A. R., J. Y. Lee, L. Zhao, D. G. Lemay, H. S. Youn, and D. H. Hwang. 2005. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J. Immunol. 174: 5390-5397.
25. Wong, S. W., M. J. Kwon, A. M. Choi, H. P. Kim, K. Nakahira, and D. H. Hwang. 2009. Fatty acids modulate Toll-like receptor 4 activation through regulation of receptor dimerization and recruitment into lipid rafts in a reactive oxygen species-dependent manner. J. Biol. Chem. 284: 27384-27392.
26. Zhao, L., M. J. Kwon, S. Huang, J. Y. Lee, K. Fukase, N. Inohara, and D. H. Hwang. 2007. Differential modulation of Nods signaling pathways by fatty acids in human colonic epithelial HCT116 cells. J. Biol. Chem. 282: 11618-11628.
27. Ehses, J. A., D. T. Meier, S. Wueest, J. Rytka, S. Boller, P. Y. Wielinga, A. Schraenen, K. Lemaire, S. Debray, L. Van Lommel, et al. 2010. Toll-like receptor 2-deficient mice are protected from insulin resistance and beta cell dysfunction induced by a high-fat diet. Diabetologia 53: 1795-1806.
28. Himes, R. W., and C. W. Smith. 2010. Tlr2 is critical for diet-induced metabolic syndrome in a murine model. FASEB J. 24: 731-739.
29. Suganami, T., T. Mieda, M. Itoh, Y. Shimoda, Y. Kamei, and Y. Ogawa. 2007. Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem. Biophys. Res. Commun. 354: 45-49.
30. Suganami, T., K. Tanimoto-Koyama, J. Nishida, M. Itoh, X. Yuan, S. Mizuarai, H. Kotani, S. Yamaoka, K. Miyake, S. Aoe, et al. 2007. Role of the Toll-like receptor 4/NF-kappaB pathway in saturated fatty acid-induced inflammatory changes in the interaction between adipocytes and macrophages. Arterioscler. Thromb. Vasc. Biol. 27: 84-91.
31. Suganami, T., X. Yuan, Y. Shimoda, K. Uchio-Yamada, N. Nakagawa, I. Shirakawa, T. Usami, T. Tsukahara, K. Nakayama, Y. Miyamoto, et al. 2009. Activating transcription factor 3 constitutes a negative feedback mechanism that attenuates saturated Fatty acid/toll-like receptor 4 signaling and macrophage activation in obese adipose tissue. Circ. Res. 105: 25-32.
32. Huang, S., J. M. Rutkowsky, R. G. Snodgrass, K. D. Ono-Moore, D. A. Schneider, J.W. Newman, S. H. Adams, and D. H. Hwang. 2012. Saturated fatty acids activate TLR-mediated proinflammatory signaling pathways. J. Lipid Res. 53: 2002-2013.
33. Liang, S., M. Wang, K. Triantafilou, M. Triantafilou, H. F. Nawar, M. W. Russell, T. D. Connell, and G. Hajishengallis. 2007. The A subunit of type IIb enterotoxin (LT-IIb) suppresses the proinflammatory potential of the B subunit and its ability to recruit and interact with TLR2. J. Immunol. 178: 4811-4819.
34. Triantafilou, M., F. G. Gamper, R. M. Haston, M. A. Mouratis, S. Morath, T. Hartung, and K. Triantafilou. 2006. Membrane sorting of toll-like receptor (TLR)-2/6 and TLR2/1 heterodimers at the cell surface determines heterotypic associations with CD36 and intracellular targeting. J. Biol. Chem. 281: 31002-31011.
35. Triantafilou, M., F. G. Gamper, P. M. Lepper, M. A. Mouratis, C. Schumann, E. Harokopakis, R. E. Schifferle, G. Hajishengallis, and K. Triantafilou. 2007. Lipopolysaccharides from atherosclerosis-Associated bacteria antagonize TLR4, induce formation of TLR2/1/CD36 complexes in lipid rafts and trigger TLR2-induced inflammatory responses in human vascular endothelial cells. Cell. Microbiol. 9: 2030-2039.
36. Triantafilou, M., M. Manukyan, A. Mackie, S. Morath, T. Hartung, H. Heine, and K. Triantafilou. 2004. Lipoteichoic acid and toll-like receptor 2 internalization and targeting to the Golgi are lipid raft-dependent. J. Biol. Chem. 279: 40882-40889.
37. Chan, J. W., D. Motton, J. C. Rutledge, N. L. Keim, and T. Huser. 2005. Raman spectroscopic analysis of biochemical changes in individual triglyceride-rich lipoproteins in the pre-And postprandial state. Anal. Chem. 77: 5870-5876.
38. Hyson, D. A., T. G. Paglieroni, T. Wun, and J. C. Rutledge. 2002. Postprandial lipemia is associated with platelet and monocyte activation and increased monocyte cytokine expression in normolipemic men. Clin. Appl. Thromb. Hemost. 8: 147-155.
39. Eiselein, L., D. W. Wilson, M. W. Lamé, and J. C. Rutledge. 2007. Lipolysis products from triglyceride-rich lipoproteins increase endothelial permeability, perturb zonula occludens-1 and F-Actin, and induce apoptosis. Am. J. Physiol. Heart Circ. Physiol. 292: H2745-H2753.
40. Wang, L., R. Gill, T. L. Pedersen, L. J. Higgins, J. W. Newman, and J. C. Rutledge. 2009. Triglyceride-rich lipoprotein lipolysis releases neutral and oxidized FFAs that induce endothelial cell inflammation. J. Lipid Res. 50: 204-213.
41. Wang, Y. I., J. Schulze, N. Raymond, T. Tomita, K. Tam, S. I. Simon, and A. G. Passerini. 2011. Endothelial inflammation correlates with subject triglycerides and waist size after a high-fat meal. Am. J. Physiol. Heart Circ. Physiol. 300: H784-H791.
42. Jin, M. S., S. E. Kim, J. Y. Heo, M. E. Lee, H. M. Kim, S. G. Paik, H. Lee, and J. O. Lee. 2007. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-Acylated lipopeptide. Cell 130: 1071-1082.
43. Aliprantis, A. O., R. B. Yang, M. R. Mark, S. Suggett, B. Devaux, J. D. Radolf, G. R. Klimpel, P. Godowski, and A. Zychlinsky. 1999. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285: 736-739.
44. Aliprantis, A. O., R. B. Yang, D. S. Weiss, P. Godowski, and A. Zychlinsky. 2000. The apoptotic signaling pathway activated by Toll-like receptor-2. EMBO J. 19: 3325-3336.
45. Miao, E. A., J. V. Rajan, and A. Aderem. 2011. Caspase-1-induced pyroptotic cell death. Immunol. Rev. 243: 206-214.
46. Fu, S., S. M. Watkins, and G. S. Hotamisligil. 2012. The role of endoplasmic reticulum in hepatic lipid homeostasis and stress signaling. Cell Metab. 15: 623-634.
47. Jenkins, K. A., and A. Mansell. 2010. TIR-containing adaptors in Toll-like receptor signalling. Cytokine 49: 237-244.
48. Jin, M. S., and J. O. Lee. 2008. Structures of the toll-like receptor family and its ligand complexes. Immunity 29: 182-191.
49. O'Neill, L. A., and A. G. Bowie. 2007. The family of five: TIR-domaincontaining adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7: 353-364.
50. Fernandez-Lizarbe, S., M. Pascual, M. S. Gascon, A. Blanco, and C. Guerri. 2008. Lipid rafts regulate ethanol-induced activation of TLR4 signaling in murine macrophages. Mol. Immunol. 45: 2007-2016.
51. Nakahira, K., H. P. Kim, X. H. Geng, A. Nakao, X. Wang, N. Murase, P. F. Drain, X. Wang, M. Sasidhar, E. G. Nabel, et al. 2006. Carbon monoxide differentially inhibits TLR signaling pathways by regulating ROS-induced trafficking of TLRs to lipid rafts. J. Exp. Med. 203: 2377-2389.
52. Olsson, S., and R. Sundler. 2006. The role of lipid rafts in LPS-induced signaling in a macrophage cell line. Mol. Immunol. 43: 607-612.
53. Shin, D. M., C. S. Yang, J. Y. Lee, S. J. Lee, H. H. Choi, H. M. Lee, J. M. Yuk, C. V. Harding, and E. K. Jo. 2008. Mycobacterium tuberculosis lipoproteininduced association of TLR2 with protein kinase C zeta in lipid rafts contributes to reactive oxygen species-dependent inflammatory signalling in macrophages. Cell. Microbiol. 10: 1893-1905.
54. Triantafilou,M., K. Miyake, D. T. Golenbock, and K. Triantafilou. 2002.Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 115: 2603-2611.
55. Triantafilou, M., S. Morath, A. Mackie, T. Hartung, and K. Triantafilou. 2004. Lateral diffusion of Toll-like receptors reveals that they are transiently confined within lipid rafts on the plasma membrane. J. Cell Sci. 117: 4007-4014.
56. Ogier-Denis, E., S. B. Mkaddem, and A. Vandewalle. 2008. NOX enzymes and Toll-like receptor signaling. Semin. Immunopathol. 30: 291-300.
57. Yang, C. S., D. M. Shin, K. H. Kim, Z. W. Lee, C. H. Lee, S. G. Park, Y. S. Bae, and E. K. Jo. 2009. NADPH oxidase 2 interaction with TLR2 is required for efficient innate immune responses to mycobacteria via cathelicidin expression. J. Immunol. 182: 3696-3705.
58. Dhungana, S., B. A. Merrick, K. B. Tomer, and M. B. Fessler. 2009. Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated ERK activation in response to lipopolysaccharide. Mol. Cell. Proteomics 8: 201-213.
59. Li, N., A. Mak, D. P. Richards, C. Naber, B. O. Keller, L. Li, and A. R. Shaw. 2003. Monocyte lipid rafts contain proteins implicated in vesicular trafficking and phagosome formation. Proteomics 3: 536-548.
60. Yang, C. S., D. M. Shin, H. M. Lee, J. W. Son, S. J. Lee, S. Akira, M. A. Gougerot-Pocidalo, J. El-Benna, H. Ichijo, and E. K. Jo. 2008. ASK1-p38 MAPK-p47phox activation is essential for inflammatory responses during tuberculosis via TLR2-ROS signalling. Cell. Microbiol. 10: 741-754.
61. Stolk, J., T. J. Hiltermann, J. H. Dijkman, and A. J. Verhoeven. 1994. Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am. J. Respir. Cell Mol. Biol. 11: 95-102.
62. Wedgwood, S., S. Lakshminrusimha, K. N. Farrow, L. Czech, S. F. Gugino, F. Soares, J. A. Russell, and R. H. Steinhorn. 2012. Apocynin improves oxygenation and increases eNOS in persistent pulmonary hypertension of the newborn. Am. J. Physiol. Lung Cell. Mol. Physiol. 302: L616-L626.
63. Buwitt-Beckmann, U., H. Heine, K. H. Wiesmüller, G. Jung, R. Brock, and A. J. Ulmer. 2005. Lipopeptide structure determines TLR2 dependent cell activation level. FEBS J. 272: 6354-6364.
64. Kitchens, R. L., R. J. Ulevitch, and R. S. Munford. 1992. Lipopolysaccharide (LPS) partial structures inhibit responses to LPS in a human macrophage cell line without inhibiting LPS uptake by a CD14-mediated pathway. J. Exp. Med. 176: 485-494.
65. Kumazawa, Y., M. Nakatsuka, H. Takimoto, T. Furuya, T. Nagumo, A. Yamamoto, Y. Homma, K. Inada, M. Yoshida, M. Kiso, et al. 1988. Importance of fatty acid substituents of chemically synthesized lipid A-subunit analogs in the expression of immunopharmacological activity. Infect. Immun. 56: 149-155.
66. Munford, R. S., and C. L. Hall. 1986. Detoxification of bacterial lipopolysaccharides (endotoxins) by a human neutrophil enzyme. Science 234: 203-205.
67. Rietschel, E. T., T. Kirikae, F. U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A. J. Ulmer, U. Zähringer, U. Seydel, F. Di Padova, et al. 1994. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J. 8: 217-225.
68. Schletter, J., H. Heine, A. J. Ulmer, and E. T. Rietschel. 1995. Molecular mechanisms of endotoxin activity. Arch. Microbiol. 164: 383-389.
69. Krauss, J. H., U. Seydel, J. Weckesser, and H. Mayer. 1989. Structural analysis of the nontoxic lipid A of Rhodobacter capsulatus 37b4. Eur. J. Biochem. 180: 519-526.
70. Qureshi, N., K. Takayama, and R. Kurtz. 1991. Diphosphoryl lipid A obtained from the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides is an endotoxin antagonist in mice. Infect. Immun. 59: 441-444.
71. Eguchi, K., I. Manabe, Y. Oishi-Tanaka, M. Ohsugi, N. Kono, F. Ogata, N. Yagi, U. Ohto, M. Kimoto, K. Miyake, et al. 2012. Saturated fatty acid and TLR signaling link b cell dysfunction and islet inflammation. Cell Metab. 15: 518-533.
72. Joosten, L. A., M. G. Netea, E. Mylona, M. I. Koenders, R. K. Malireddi, M. Oosting, R. Stienstra, F. L. van de Veerdonk, A. F. Stalenhoef, E. J. Giamarellos-Bourboulis, et al. 2010. Engagement of fatty acids with Tolllike receptor 2 drives interleukin-1b production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum. 62: 3237-3248.
73. Kim, F., M. Pham, I. Luttrell, D. D. Bannerman, J. Tupper, J. Thaler, T. R. Hawn, E. W. Raines, and M. W. Schwartz. 2007. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ. Res. 100: 1589-1596.
74. Schaeffler, A., P. Gross, R. Buettner, C. Bollheimer, C. Buechler, M. Neumeier, A. Kopp, J. Schoelmerich, and W. Falk. 2009. Fatty acid-induced induction of Toll-like receptor-4/nuclear factor-kappaB pathway in adipocytes links nutritional signalling with innate immunity. Immunology 126: 233-245.
75. Schwartz, E. A., W. Y. Zhang, S. K. Karnik, S. Borwege, V. R. Anand, P. S. Laine, Y. Su, and P. D. Reaven. 2010. Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation. Arterioscler. Thromb. Vasc. Biol. 30: 802-808.
76. Senn, J. J. 2006. Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes. J. Biol. Chem. 281: 26865-26875.
77. Bourguignon, L. Y., C. C. Spevak, G. Wong, W. Xia, and E. Gilad. 2009. Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, antiapoptosis, and chemotherapy resistance in breast tumor cells. J. Biol. Chem. 284: 26533-26546.
78. Triantafilou, M., P. M. Lepper, R. Olden, I. S. Dias, and K. Triantafilou. 2011. Location, location, location: is membrane partitioning everything when it comes to innate immune activation? Mediators Inflamm. 2011: 186093.
79. Latz, E., A. Verma, A. Visintin, M. Gong, C. M. Sirois, D. C. Klein, B. G. Monks, C. J. McKnight, M. S. Lamphier, W. P. Duprex, et al. 2007. Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat. Immunol. 8: 772-779.
80. Tapping, R. I., and P. S. Tobias. 2003. Mycobacterial lipoarabinomannan mediates physical interactions between TLR1 and TLR2 to induce signaling. J. Endotoxin Res. 9: 264-268.
81. Yan, Y., W. Jiang, T. Spinetti, A. Tardivel, R. Castillo, C. Bourquin, G. Guarda, Z. Tian, J. Tschopp, and R. Zhou. 2013. Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation. Immunity 38: 1154-1163.
82. Bedard, K., and K. H. Krause. 2007. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87: 245-313.
83. DeLeo, F. R., J. Renee, S. McCormick, M. Nakamura, M. Apicella, J. P. Weiss, and W. M. Nauseef. 1998. Neutrophils exposed to bacterial lipopolysaccharide upregulate NADPH oxidase assembly. J. Clin. Invest. 101: 455-463.
84. Simon, F., and R. Fernández. 2009. Early lipopolysaccharide- induced reactive oxygen species production evokes necrotic cell death in human umbilical vein endothelial cells. J. Hypertens. 27: 1202-1216.
85. Ago, T., T. Liu, P. Zhai, W. Chen, H. Li, J. D. Molkentin, S. F. Vatner, and J. Sadoshima. 2008. A redox-dependent pathway for regulating class II HDACs and cardiac hypertrophy. Cell 133: 978-993.
86. Cumming, R. C., N. L. Andon, P. A. Haynes, M. Park, W. H. Fischer, and D. Schubert. 2004. Protein disulfide bond formation in the cytoplasm during oxidative stress. J. Biol. Chem. 279: 21749-21758.
87. Miki, H., and Y. Funato. 2012. Regulation of intracellular signalling through cysteine oxidation by reactive oxygen species. J. Biochem. 151: 255-261.
88. Yang, Y., Y. Song, and J. Loscalzo. 2007. Regulation of the protein disulfide proteome by mitochondria in mammalian cells. Proc. Natl. Acad. Sci. USA 104: 10813-10817.
89. Tao, X., Y. Xu, Y. Zheng, A. A. Beg, and L. Tong. 2002. An extensively associated dimer in the structure of the C713S mutant of the TIR domain of human TLR2. Biochem. Biophys. Res. Commun. 299: 216-221.